AI-Driven Technology Stocks Present Compelling Buying Opportunities Amid Market Volatility

The current market pullback offers a strategic window for long-term investors to accumulate quality AI and technology holdings. While geopolitical tensions and economic uncertainties have created short-term headwinds, the fundamental drivers supporting the technology sector remain robust. History demonstrates that disciplined investors who deploy capital during market weakness often achieve superior returns over multi-year horizons.

The technology sector’s resilience stems from two powerful secular trends. First, corporate earnings growth continues to accelerate across the technology landscape, with 15 of 16 Zacks sectors expected to deliver year-over-year earnings expansion through 2027. Second, the Federal Reserve’s current monetary posture suggests additional rate cuts may emerge in the second half of 2026, providing additional tailwinds for growth-oriented equities.

Strategic Positioning in AI Biotech and Infrastructure Investment

The AI biotech and technology infrastructure investment boom represents one of the most significant capital allocation trends in modern markets. Taiwan Semiconductor Manufacturing Company elevated its capital expenditure guidance to between $52 billion and $56 billion for 2026, up substantially from $40.9 billion in 2025. This aggressive capital deployment underscores the intensity of competition in advanced semiconductor manufacturing.

The broader AI ecosystem is absorbing enormous amounts of capital. Collectively, AI hyperscalers are projected to deploy approximately $530 billion in capital expenditure during 2026, representing a 32% increase from roughly $400 billion deployed in 2025. This accelerating investment trajectory reflects not merely cyclical demand but rather a fundamental restructuring of business computing infrastructure around AI-native architectures.

Technology sector guidance for Q1 2026 earnings has surged to 24% growth compared to just 18% in mid-January and 12% in early October. This expanding outlook reflects both the direct beneficiaries of AI adoption—semiconductor and software companies—and indirect beneficiaries across the broader technology ecosystem.

Celestica: The Infrastructure-Enabling Powerhouse Down 25%

Among pure-play AI beneficiaries, Celestica Inc. (CLS) operates as a critical behind-the-scenes manufacturer of enterprise-grade AI infrastructure. The company designs and manufactures sophisticated electronic solutions including high-performance AI servers, networking equipment, and specialized data-center hardware for leading hyperscalers and technology innovators.

This electronics manufacturing titan emerged from years of operational challenges to become a dominant player in the AI infrastructure arms race. In 2025, Celestica expanded its revenue by 29% to $12.39 billion, continuing a remarkable expansion that has more than doubled revenues since 2021. More impressively, the company grew adjusted earnings by 56% in 2025 while expanding GAAP earnings per share by over 90%.

The company’s growth trajectory reflects sustained demand for AI infrastructure deployment. CEO Rob Mionis emphasized during Q4 remarks that Celestica continues supporting customers’ multi-year AI infrastructure investment plans. This strategic positioning compelled management to increase planned capital investments to $1 billion during 2026, fully funded through operational cash generation.

Forward guidance remains robust. Analysts project Celestica will expand revenue by 37% in 2026 and 39% in 2027, reaching approximately $23.66 billion—nearly double 2025 levels. Adjusted earnings are expected to expand by 46% and 43% respectively. These projections have earned Celestica a Zacks Rank #2 (Buy) designation, with 15 of 18 brokerage recommendations classified as “Strong Buy.”

The stock’s five-year performance has been extraordinary, surging approximately 3,000% and substantially outpacing the broader technology sector’s 100% return. Despite a recent 12-month run of 220% gains, investors have an entry opportunity following the roughly 25% pullback from November highs. The company trades at approximately 30.0X forward 12-month earnings, representing a 50% discount to recent peaks. At current levels, the average Zacks price target suggests 34% additional upside.

ServiceNow: Software Excellence Adapted for AI Integration

The second compelling opportunity exists within ServiceNow (NOW), which has declined nearly 50% from its early 2025 peak. This pullback presents approximately 100% recovery potential if the stock returns to those previous levels.

ServiceNow exemplifies how enterprise software companies are successfully adapting to AI-driven market dynamics. Rather than succumbing to technology disruption, the company has deeply embedded artificial intelligence capabilities across its portfolio. ServiceNow provides digital workflow solutions for IT operations, customer service, human resources, and general business operations.

The company’s AI positioning reflects direct partnerships with leading artificial intelligence innovators. In January 2026, ServiceNow deepened its multi-year relationship with OpenAI to integrate advanced agentic AI experiences that accelerate enterprise outcomes. Simultaneously, the company expanded collaboration with Anthropic to embed Claude models more extensively throughout the ServiceNow AI Platform.

ServiceNow’s financial performance validates its AI adaptation strategy. The company maintained 21-24% annual revenue growth throughout 2025, reaching $13.28 billion—substantially more than double its 2021 revenues. During Q4 2025, the company executed 244 transactions exceeding $1 million in net new annual contract value, representing 40% year-over-year growth. Premium customers with more than $5 million in annual contract value expanded to over 600 accounts, up 20% versus 2024.

Profitability metrics similarly demonstrate execution quality. GAAP earnings per share expanded by 22% to $1.67, compared to just $0.23 in 2021. Adjusted earnings per share expanded 27%, reflecting operational leverage in the business model.

Forward estimates project 20% revenue growth during 2026 and 18% during 2027, driving adjusted earnings expansion of 18% and 20% respectively. Post-earnings estimate revisions from the January Q4 release have remained constructive. Management demonstrated conviction by authorizing an additional $5 billion share repurchase program, while CEO Bill McDermott personally invested $3 million in company equity at recent prices.

ServiceNow’s stock chart reveals technical support at the 200-day moving average, with recent trading near the 50-day technical level. The stock currently offers average Zacks price target upside of approximately 70% from current levels. Investors acquiring shares at present depressed valuations have opportunity to capture substantial appreciation as earnings expectations normalize.

Market Fundamentals Support Continued Allocation

The investment case for technology and AI biotech stocks rests upon two durable foundations. Earnings expansion continues to accelerate across sectors, with double-digit growth expected through 2026 and beyond. Interest rate dynamics increasingly favor growth equities, with fixed income markets pricing multiple Fed rate reductions for the second half of 2026.

Technology companies most directly exposed to AI infrastructure buildout and enterprise software adoption appear particularly well-positioned. Both Celestica and ServiceNow combine robust growth with reasonable valuations following recent pullbacks, offering asymmetric risk-reward profiles for patient capital deployment.

The current environment rewards disciplined accumulation of best-in-class technology positions during moments of market weakness.